Table 4 Antibodies used in the study.
From: PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
Antibody | Vendor | Clone or ID | Platform | Pre-treatment | Dilution |
|---|---|---|---|---|---|
PSMA | Dako | clone 3E6 | Dako | EnVision FLEX™ High pH, 20′ at 95 °C | Pre-diluted, 20′ at RT |
CD31 | Dako | clone JC70A | Dako | EnVision FLEX™ High pH, 20′ at 95 °C | Pre-diluted, 20′ at RT |
CD34 | Dako | clone QBEnd 10 | Dako | EnVision FLEX™ High pH, 20′ at 95 °C | Pre-diluted, 30′ at RT |
CD105 | Abcam | ab170943 | Ventana | CC1 mild, 30′ at 95 °C | 1:500, 32′ at 37 °C |
